Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121039262 | 12103926 | 2 | F | 2015 | 20160727 | 20160223 | 20160804 | EXP | BE-ASTRAZENECA-2016SE18288 | ASTRAZENECA | 81.00 | YR | M | Y | 60.00000 | KG | 20160805 | MD | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121039262 | 12103926 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | 91500 | MG | Y | 206995 | 250 | MG | TABLET | QD | ||||
| 121039262 | 12103926 | 2 | C | COVERSYL PLUS | INDAPAMIDEPERINDOPRIL | 1 | 5/1.25 MG 1 TABLET /DAY | 0 | TABLET | ||||||||||
| 121039262 | 12103926 | 3 | C | ASAFLOW | ASPIRIN | 1 | 0 | ||||||||||||
| 121039262 | 12103926 | 4 | C | PRAREDUCT | 2 | 0 | 40 | MG | QD | ||||||||||
| 121039262 | 12103926 | 5 | C | PANTOMED | DEXPANTHENOL | 1 | 0 | 40 | MG | QD | |||||||||
| 121039262 | 12103926 | 6 | C | RIVOTRIL | CLONAZEPAM | 1 | 0 | .5 | DF | QD | |||||||||
| 121039262 | 12103926 | 7 | C | DUOVENT | FENOTEROL HYDROBROMIDE | 1 | 0 | 2 | DF | QID | |||||||||
| 121039262 | 12103926 | 8 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 25/250 MG 2 PUFFS 2 TIMES A DAY | 0 | |||||||||||
| 121039262 | 12103926 | 9 | C | CINNARIZINE EG | 2 | 0 | 75 | MG | QD | ||||||||||
| 121039262 | 12103926 | 10 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 121039262 | 12103926 | 11 | C | ZALDIAR | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | AS REQUIRED IN CASE OF PAIN | 0 | |||||||||||
| 121039262 | 12103926 | 12 | C | DUROGESIC | FENTANYL | 1 | 0 | 1 | DF | TRANSDERMAL PATCH | |||||||||
| 121039262 | 12103926 | 13 | C | FEROGRADUMET | 2 | 0 | 525 | MG | QD | ||||||||||
| 121039262 | 12103926 | 14 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1000 GAMMA B12, ONCE A WEEK | 0 | ||||||||||
| 121039262 | 12103926 | 15 | C | FOLAVIT | 2 | 0 | 4 | MG | QD | ||||||||||
| 121039262 | 12103926 | 16 | C | DAFALGAN | ACETAMINOPHEN | 1 | AS REQUIRED BUT MAX 4 TIMES A DAY | 0 | |||||||||||
| 121039262 | 12103926 | 17 | C | MITOSYL | 2 | 2 TIMES A DAY, LOCAL APPLICATION | 0 | OINTMENT | |||||||||||
| 121039262 | 12103926 | 18 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 0 | 875 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121039262 | 12103926 | 1 | Lung neoplasm malignant |
| 121039262 | 12103926 | 11 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121039262 | 12103926 | HO |
| 121039262 | 12103926 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121039262 | 12103926 | Abasia | |
| 121039262 | 12103926 | Abnormal behaviour | |
| 121039262 | 12103926 | Anaemia | |
| 121039262 | 12103926 | Asthenia | |
| 121039262 | 12103926 | Cholecystitis acute | |
| 121039262 | 12103926 | Cholelithiasis | |
| 121039262 | 12103926 | Chronic obstructive pulmonary disease | |
| 121039262 | 12103926 | Cystitis pseudomonal | |
| 121039262 | 12103926 | Decreased appetite | |
| 121039262 | 12103926 | Diarrhoea | |
| 121039262 | 12103926 | Dysphagia | |
| 121039262 | 12103926 | Encephalopathy | |
| 121039262 | 12103926 | Fall | |
| 121039262 | 12103926 | Fatigue | |
| 121039262 | 12103926 | General physical health deterioration | |
| 121039262 | 12103926 | Lung adenocarcinoma stage IV | |
| 121039262 | 12103926 | Malignant pleural effusion | |
| 121039262 | 12103926 | Metastases to meninges | |
| 121039262 | 12103926 | Mobility decreased | |
| 121039262 | 12103926 | Muscular weakness | |
| 121039262 | 12103926 | Pneumonia | |
| 121039262 | 12103926 | Pyogenic granuloma | |
| 121039262 | 12103926 | Pyrexia | |
| 121039262 | 12103926 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121039262 | 12103926 | 1 | 20141225 | 20160209 | 0 | |
| 121039262 | 12103926 | 18 | 20160301 | 0 |